Concerns regarding albumin in sepsis include the lack of clear benefits, increased costs, and safety issues such as the risks of hypervolemia, pulmonary complications, myocardial insufficiency, and hemorrhagic complications [17]. This evidence concerns the gene ALB and Sepsis.